¼¼°è ÁøÇØÁ¦ ¹× °¨±â¾à ½ÃÀå º¸°í¼­(2024³â)
Cough And Cold Preparations Global Market Report 2024
»óǰÄÚµå : 1429380
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,000 £Ü 6,886,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,500 £Ü 10,329,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,772,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÁøÇØÁ¦ ¹× °¨±â¾à ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³âµ¿¾È Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2028³â º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 5.1%¸¦ ³ªÅ¸³¾ Àü¸ÁÀ̸ç 1,043¾ï 1,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹»óµÇ´Â ¼ºÀåÀº ÀüÀÚ ´ã¹è/ÀüÀÚ ´ã¹è Áõ°¡, ºñ¸¸·ü Áõ°¡, Áø´ÜµÇÁö ¾ÊÀº Àα¸ Áõ°¡ ¹× Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê ¶§¹®ÀÔ´Ï´Ù. ÁÖ¿ä µ¿Çâ¿¡´Â õ½Ä¿ë ÇÁ·Î¹ÙÀÌ¿Àƽ½º, °í±Þ ±â°üÁö È®ÀåÁ¦, ½ÅÁ¦Ç° Ãâ½Ã, ½ÃÀå Á¦ÈÞ, ¸ÂÃãÇü ÀÇ·á, ¿¡¾î·ÎÁ¹ È£Èí±â ¾à¹°, ÀÏ¹Ý È£Èí±â ¾à¹°, COPD º´¿ë ¿ä¹ýÀÌ Æ÷ÇԵ˴ϴÙ.

ÁøÇØÁ¦ ¹× °¨±â¾à ½ÃÀåÀÇ ¼ºÀåÀº ¿¹Ãø ±â°£ µ¿¾È ¾Ë·¹¸£±â ¹ß»ý·ü Áõ°¡¿¡ ÀÇÇØ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ²É°¡·ç, ¸ÕÁö, °õÆÎÀÌ, ¹Ý·Áµ¿¹° ºñµëÀ¸·Î ÀÎÇÑ °ÍµéÀ» Æ÷ÇÔÇÑ È£Èí±â ¾Ë·¹¸£±â´Â ¾ß¿Ü ¹× ½Ç³» °ø±â ¿À¿°À¸·Î ÀÎÇØ Áõ°¡ÇÏ´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. ÁøÇØÁ¦ ¹× °¨±â¾àÀº ±âħÀ̳ª È£Èí±âÀÇ ¹®Á¦·Î ³ªÅ¸³ª´Â ¾Ë·¹¸£±â¿¡ ´ëóÇÏ´Â µ¥ ÀÚÁÖ »ç¿ëµË´Ï´Ù. ¿¹¸¦ µé¾î, À¯·´ ¾Ë·¹¸£±â ¹× ÀÓ»ó ¸é¿ª ÇÐȸ´Â 2025³â±îÁö À¯·´ ¿¬ÇÕ ³» 3¸í Áß 1¸íÀÌ ¾Ë·¹¸£±â¿¡ °É¸± °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ È£Èí±â ¾Ë·¹¸£±âÀÇ ±ÞÁõÀ¸·Î ÁøÇØÁ¦ ¹× °¨±â¾à¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ½ÃÀå ¼ºÀå¿¡ ±àÁ¤Àû ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÁøÇØÁ¦ ¹× °¨±â¾à ½ÃÀåÀÇ ¼ºÀåÀº ³ëÀÎ Àα¸ Áõ°¡¿¡ ÀÇÇØ ´õ¿í °¡¼ÓµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 65¼¼ ÀÌ»óÀÇ ³ëÀεéÀº ¸é¿ª·ÂÀÌ ÀúÇϵǴ °æ¿ì°¡ ¸¹¾Æ ±âħÀ̳ª °¨±â µîÀÇ È£Èí±â °¨¿°¿¡ °É¸®±â ½¬¿öÁý´Ï´Ù. ÀÌ Ãë¾àÁ¡ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ±âħ°ú °¨±â Ä¡·áÁ¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. 2022³â 10¿ù ¼¼°èº¸°Ç±â±¸(WHO) º¸°í¼­¿¡ µû¸£¸é ¼¼°è 6¸í Áß 1¸íÀÌ 2030³â±îÁö 60¼¼ ÀÌ»óÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àü ¼¼°è 80¼¼ ÀÌ»óÀÇ Àα¸´Â 2020³âºÎÅÍ 2020³â »çÀÌ¿¡ 4¾ï 2,600¸¸ ¸í Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. 2050³â. °í·ÉÈ­¸¦ ÇâÇÑ Àα¸µ¿ÅÂÀÇ º¯È­´Â ÁøÇØÁ¦ ¹× °¨±â¾à ½ÃÀåÀÇ ¼ºÀå¿¡ Áß¿äÇÑ ÃßÁø·ÂÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ª ¹× ±¹°¡ ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ¼±µµÀûÀ̰í Çõ½ÅÀûÀÎ ±â¾÷

Á¦32Àå °æÀï º¥Ä¡¸¶Å·

Á¦33Àå °æÀï ´ë½Ãº¸µå

Á¦34Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦35Àå ¹Ì·¡ Àü¸Á°ú °¡´É¼º ºÐ¼®

Á¦36Àå ºÎ·Ï

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Cold and cough preparations encompass medications designed to alleviate symptoms associated with these conditions. These drugs target receptors where the infecting virus attaches, countering the receptor's action, eradicating viral infection, and reducing congestion by breaking down mucus and expanding constricted bronchioles.

Primary drug categories in cold and cough preparations consist of antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and other similar treatments. Antihistamines mitigate histamine's effects and are commonly used to address allergies. Varieties include bronchodilators, anticholinergic, and pulmonary antihypertensives. These medications are available in various forms such as oral syrups, tablets, nasal drops, lozenges, and others. Distribution occurs through hospital pharmacies, retail pharmacies, drug stores, and similar channels.

The cold and cough preparations market research report is one of a series of new reports from The Business Research Company that provides cold and cough preparations market statistics, including cold and cough preparations industry global market size, regional shares, competitors with a cold and cough preparations market share, detailed cold and cough preparations market segments, market trends and opportunities, and any further data you may need to thrive in the cold and cough preparations industry. This cold and cough preparations market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cough and cold preparations market size has grown strongly in recent years. It will grow from $80.96 billion in 2023 to $85.36 billion in 2024 at a compound annual growth rate (CAGR) of 5.4%. Historical growth can be attributed to several factors, including the increased prevalence of respiratory diseases, higher rates of tobacco smoking, global warming, robust economic growth in emerging markets, and an upsurge in healthcare expenditure.

The cough and cold preparations market size is expected to see strong growth in the next few years. It will grow to $104.31 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. Forecasted growth stems from the rise in e-cigarettes/vaping, increasing obesity rates, a sizable undiagnosed population, and government initiatives. Major trends include probiotics for asthma, advanced bronchodilators, new product launches, market collaborations, personalized medicines, aerosol respiratory drugs, generic respiratory drugs, and combination therapy for COPD.

The growth of the cough and cold preparations market is anticipated to be fueled by the rising incidence of allergies in the forecast period. Respiratory allergies, including those triggered by pollen, dust, mold, and pet dander, are on the ascent due to contaminated outdoor and indoor air. Cough and cold preparations are commonly used to address allergies that manifest as coughs and respiratory issues. For example, the European Academy of Allergy and Clinical Immunology projects that by 2025, one in every three people in the European Union will be affected by allergies. This surge in respiratory allergies is expected to drive demand for cough and cold preparations, positively influencing market growth.

The growth of the cough and cold preparations market is expected to receive a boost from the increasing geriatric population. The elderly, aged 65 and older, often have weaker immune systems, making them more susceptible to respiratory infections such as coughs and colds. This heightened vulnerability contributes to a greater demand for cough and cold remedies. According to a report by the World Health Organization (WHO) in October 2022, one in six people globally is expected to be 60 or older by 2030. The worldwide population of individuals aged 80 or older is projected to increase by 426 million between 2020 and 2050. This demographic shift toward an aging population is a significant driver of the growth in the cough and cold preparations market.

Advancements in technologies are playing a pivotal role in shaping the global pharmaceutical sector, and this impact extends to cold and cough preparations. As outlined in a global life sciences report by Deloitte, various cutting-edge technologies are driving the life sciences sector, including the pharmaceutical domain. Some of these transformative technologies include AI, robotic automation, the Internet of Medical Things (IoMT), blockchain, DIY diagnostics, virtual care, mobility in drug delivery and clinical trials, genomics, next-generation therapies, cloud computing, Real-World Evidence (RWE), and data-driven precision medicine. AI technology is being harnessed for diagnoses, treatment planning, patient monitoring, and drug discovery. The IoMT is facilitating the emergence of new business models and enhancing customer experiences. Biomarkers, which are biological indicators objectively measured and evaluated for various processes, are increasingly being utilized in the drug development process to expedite product launches.

Major companies in the cough and cold preparations market are responding to these technological advancements by developing new products, such as herbal cough syrups, to cater to larger customer bases, drive more sales, and increase revenue. Herbal cough syrups are liquid formulations made from natural or plant-based ingredients, typically incorporating herbs, botanical extracts, and other organic compounds. These products aim to alleviate symptoms of coughs and colds. For example, Dexa Medica, an Indonesia-based pharmaceutical company, launched Herbacough in May 2021. Herbacough is a herbal cough syrup known for its unique qualities, including the absence of side effects or addictive tendencies. Positioned as an effective treatment for various types of coughs, Herbacough boasts benefits such as soothing sore throats, easing breathing, warming the respiratory tract, and relieving different forms of coughs. The product employs the latest fractionation technology, an extraction method isolating a specific active substance, reconyl, making it a safe and efficient remedy for cough and sore throat issues.

The cold and cough preparations market is subject to regulatory oversight by authorities, such as the Food and Drug Administration (FDA) in the United States. An example of regulatory action is the FDA's restriction on the use of codeine in children. Codeine, although approved for pain and cough treatment, poses serious risks, including the potential for slowed or difficult breathing, and can be fatal. The FDA has recognized a higher risk of these adverse effects in children under the age of 12, leading to restrictions on the use of codeine even in some older children. Single-ingredient codeine is FDA-approved solely for use in adults. Additionally, the FDA recommends against the use of codeine in breastfeeding mothers due to the potential harm it may pose to their infants. This regulatory intervention reflects a commitment to ensuring the safety of pharmaceutical products, especially those intended for vulnerable populations such as children and breastfeeding mothers.

Major companies operating in the cough and cold preparations market report are Johnson & Johnson, GlaxoSmithKline PLC, Procter & Gamble, Bayer AG, Reckitt Benckiser Group PLC, Novartis AG, Perrigo Company, Sun Pharmaceutical Industries Ltd., Prestige Consumer Healthcare, Blackmores Limited, AFT Pharmaceuticals, Dexa Medica, Glenmark Pharmaceuticals Limited, Wockhardt Ltd., Apnar Pharma LP, Hanmi Pharmaceutical, Cipla Limited, Aurobindo Pharma Limited, KYORIN Holdings, Inc., Nichi-Iko Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd. , China National Pharmaceutical Group Co., Ltd., Shanghai Anovent Pharma, Shanghai Acebright Pharmaceuticals Group Co., Ltd., China Meheco Group Co., Ltd. , Merck & Co, Abbott Laboratories, Boehringer Ingelheim, Roche Holding AG, Vectura Group, Pfizer, Mylan, Teva Pharmaceutical Industries Ltd., Sanofi, W. K. Buckley Limited, BENYLIN, Sanfer, PROBIOMED, PiSA, EMS Pharma, Hypermarcas, Ache, Eurofarma, Biolab Farmaceuticad, Cristalia, Libbs, AstraZeneca, Neopharma, Regal Pharmaceuticals, Adcock Ingram, Aspen Pharmacare

North America was the largest region in the cold and cough preparation market share in 2023. Middle East is expected to be the fastest-growing region in the global cough and cold preparations market during the forecast period. The regions covered in the cough and cold preparations market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cough and cold preparations market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The cold and cough preparations market consists of sales of dextromethorphan, guaifenesin, and phenylephrine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cough And Cold Preparations Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cough and cold preparations market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cough and cold preparations? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cough and cold preparations market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Scope

Markets Covered:

Table of Contents

1. Executive Summary

2. Cough And Cold Preparations Market Characteristics

3. Cough And Cold Preparations Market Trends And Strategies

4. Cough And Cold Preparations Market - Macro Economic Scenario

5. Global Cough And Cold Preparations Market Size and Growth

6. Cough And Cold Preparations Market Segmentation

7. Cough And Cold Preparations Market Regional And Country Analysis

8. Asia-Pacific Cough And Cold Preparations Market

9. China Cough And Cold Preparations Market

10. India Cough And Cold Preparations Market

11. Japan Cough And Cold Preparations Market

12. Australia Cough And Cold Preparations Market

13. Indonesia Cough And Cold Preparations Market

14. South Korea Cough And Cold Preparations Market

15. Western Europe Cough And Cold Preparations Market

16. UK Cough And Cold Preparations Market

17. Germany Cough And Cold Preparations Market

18. France Cough And Cold Preparations Market

19. Italy Cough And Cold Preparations Market

20. Spain Cough And Cold Preparations Market

21. Eastern Europe Cough And Cold Preparations Market

22. Russia Cough And Cold Preparations Market

23. North America Cough And Cold Preparations Market

24. USA Cough And Cold Preparations Market

25. Canada Cough And Cold Preparations Market

26. South America Cough And Cold Preparations Market

27. Brazil Cough And Cold Preparations Market

28. Middle East Cough And Cold Preparations Market

29. Africa Cough And Cold Preparations Market

30. Cough And Cold Preparations Market Competitive Landscape And Company Profiles

31. Cough And Cold Preparations Market Other Major And Innovative Companies

32. Global Cough And Cold Preparations Market Competitive Benchmarking

33. Global Cough And Cold Preparations Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cough And Cold Preparations Market

35. Cough And Cold Preparations Market Future Outlook and Potential Analysis

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â